TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis

Affiliation auteursAffiliation ok
TitreTOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis
Type de publicationJournal Article
Year of Publication2020
AuteursEven C., Daste A., Fayette J., Lefebvre G., Saada-Bouzid E., Zanetta S., Toullec C., Cupissol D., Salas S., Kaminski M.C, Johnson A.C, Vauleon E., Le Tourneau C., Sire C., Prevost A., Jallut I., Bourhis J., Guigay J., Auperin A., Texier M.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS662
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.1032